Matthew Yeowart
Lawyers
Filters
IREN $625 million acquisition of Mirantis
We are advising IREN on the transaction
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Anthology chapter 11 restructuring
We advised an ad hoc group of creditors on the restructuring
Global Eggs investment of up to $1 billion from Warburg Pincus
We are advising Global Eggs on the transaction
Rhône Capital acquisition of Invacare
We advised Highbridge Capital, as an Invacare secured lender and noteholder, on the transaction
AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca
We advised AbelZeta on the transaction
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
bit.bio $50 million Series C equity financing
We are advising the company on the funding round
GSK strategic collaboration with CAMP4 Therapeutics
We advised GSK on the transaction
Semrush Holdings $1.9 billion sale to Adobe
We are advising Semrush on the transaction